A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital

Nanthini R; Mamatha K R; Geeta Shivmurthy; Kavitha

doi:10.5455/njppp.2017.7.0100229012017

2023, Vol: 13, Issue: 5

13/5Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

Authorship Declaration

« Previous Article

Original Research

Natl J Physiol Pharm Pharmacol. 2017; 7(5): 545-551

doi: 10.5455/njppp.2017.7.0100229012017

A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital

Nanthini R, Mamatha K R, Geeta Shivmurthy, Kavitha.

Abstract
Background: The prevalence of iron deficiency anemia (IDA) is 58% among pregnant women in developing countries. According to the recent national guidelines, intramuscular iron sorbitol citric acid (ISCA) complex is one of the firstline drugs for treating moderate IDA in pregnancy. A novel intravenous preparation, iron sucrose promises to be more effective as it causes faster replenishment of iron stores and rapid rise of hemoglobin (Hb).

Aims and Objective: The aim of this study is to evaluate the efficacy and safety of iron sucrose versus ISCA complex in IDA of pregnant women.

Materials and Methods: A total of 127 pregnant women whose Hb between 7 and 9 g/dl were recruited in the study. They were randomized into two groups to receive iron sucrose (intravenous) and ISCA (I.M), respectively. Hematological parameters were measured at baseline, 4 weeks and 8 weeks of treatment. Results: Mean rise in Hb and serum ferritin from baseline was 3.15 ± 0.08 (P < 0.0001) and 14.1 ± 2.6 (P < 0.0001) at the end of 8 weeks, respectively, with ISCA. Mean rise in Hb and serum ferritin from baseline was 3.36 ± 0.06 (P < 0.0001) and 16.28 ± 3.1 (P < 0.0001) at the end of 8 weeks with iron sucrose. 18% and 42% of pregnant women in iron sucrose and ISCA group experienced side effects, respectively.

Conclusion: The rise in hemoglobin and serum ferritin was significant in iron sucrose group with fewer adverse effects. Hence, iron sucrose can be a safe and effective agent in the treatment of IDA in pregnancy.

Key words: Iron Deficiency Anemia; Pregnant Women; Iron Sucrose; Iron Sorbitol Citric Acid Complex

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Nanthini R Articles by Mamatha K R Articles by Geeta Shivmurthy Articles by Kavitha
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

Nanthini R, Mamatha K R, Geeta Shivmurthy, Kavitha. A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2017; 7(5): 545-551. doi:10.5455/njppp.2017.7.0100229012017

Web Style

Nanthini R, Mamatha K R, Geeta Shivmurthy, Kavitha. A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital. https://www.njppp.com/?mno=254631 [Access: May 01, 2023]. doi:10.5455/njppp.2017.7.0100229012017

AMA (American Medical Association) Style

Nanthini R, Mamatha K R, Geeta Shivmurthy, Kavitha. A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. 2017; 7(5): 545-551. doi:10.5455/njppp.2017.7.0100229012017

Vancouver/ICMJE Style

Nanthini R, Mamatha K R, Geeta Shivmurthy, Kavitha. A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital. Natl J Physiol Pharm Pharmacol. (2017), [cited May 01, 2023]; 7(5): 545-551. doi:10.5455/njppp.2017.7.0100229012017

Harvard Style

Nanthini R, Mamatha K R, Geeta Shivmurthy, Kavitha (2017) A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital. Natl J Physiol Pharm Pharmacol, 7 (5), 545-551. doi:10.5455/njppp.2017.7.0100229012017

Turabian Style

Nanthini R, Mamatha K R, Geeta Shivmurthy, Kavitha. 2017. A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 7 (5), 545-551. doi:10.5455/njppp.2017.7.0100229012017

Chicago Style

Nanthini R, Mamatha K R, Geeta Shivmurthy, Kavitha. "A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 7 (2017), 545-551. doi:10.5455/njppp.2017.7.0100229012017

MLA (The Modern Language Association) Style

Nanthini R, Mamatha K R, Geeta Shivmurthy, Kavitha. "A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital." National Journal of Physiology, Pharmacy and Pharmacology 7.5 (2017), 545-551. Print. doi:10.5455/njppp.2017.7.0100229012017

APA (American Psychological Association) Style

Nanthini R, Mamatha K R, Geeta Shivmurthy, Kavitha (2017) A comparative prospective study to assess the efficacy and safety of iron sucrose versus iron sorbitol citric acid in pregnant women with iron deficiency anemia in a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 7 (5), 545-551. doi:10.5455/njppp.2017.7.0100229012017

Author Login Reviewer Login About Publisher Editorial Policies Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information



Copyright © 2023 National Journal of Physiology, Pharmacy and Pharmacology All Rights Reserved. Subject to change without notice from or liability to National Journal of Physiology, Pharmacy and Pharmacology. For best results, please use Internet Explorer or Google Chrome	Contact Information Publisher publishernjppp@gmail.com Editorial query editornjppp1@gmail.com MOB - 8780040272

Contact Information

How to cite this article